Prevention of neutrophil recruitment

Organic compounds -- part of the class 532-570 series – Organic compounds – Fatty compounds having an acid moiety which contains the...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C554S213000, C554S227000, C558S303000, C568S022000, C568S028000, C514S553000, C514S560000, C514S706000, C514S718000, C514S532000, C560S055000

Reexamination Certificate

active

07579494

ABSTRACT:
Aspirin (ASA) triggers a switch in the biosynthesis of lipid mediators, inhibiting prostanoid production and initiating 15-epi-lipoxin generation, through the acetylation of cyclooxygenase II.

REFERENCES:
patent: 5441951 (1995-08-01), Serhan
patent: 6433202 (2002-08-01), Serhan
patent: 6720354 (2004-04-01), Serhan
patent: 6960674 (2005-11-01), Serhan
patent: 7227031 (2007-06-01), Serhan
patent: 2003/0191332 (2003-10-01), Serhan
patent: 9811049 (1998-03-01), None
patent: 0054761 (2000-09-01), None
patent: 03039533 (2003-05-01), None
Weissmann, G. (1991) Sci. Am. 264,84-90.
Ridker, P. M., Cushman, M., Stampfer, M. J., Tracy, R. P. & Hennekens, C. H. (1997) N. Engl. J. Med. 336, 973-979.
Hennekens, C. H. (1997) N. Engl. J. Med. 336, 973-979.
Marcus, A. J. (1995) N. Engl. J. Med. 333, 656-658.
Herschman, H.R. (1998) Trends Cardiovasc. Med. 8, 145-150.
Serhan, C. N. (1997) Prostaglandins 53, 107-137.
Chiang, N., Takano, T., Clish, C. B. Petasis, N. A., Tai, H.-H. & Serhan, C. N. (1998) J. Pharmacol. Exp. Ther. 287, 779-790.
Lee, T. H., Crea, A. E., Gant, V., Spur, B. W., Marron, B. E., Nicolaou, K. C., Reardon, E., Brezinski, M. & Serhan, C. N. (1990) Am. Rev. Respir. Dis. 141, 1453-1458.
Chavis, C., Vachier, I., Chanez, P., Bousquet, J., Michael F. B. & Godard, P. (1995) Biochem. Biophys. Res. Commun. 207, 273-279.
Chavis, C., Vachier, I., Chanez, P., Bousquet, J. & Godard, P. (1996) J. Exp. Med. 183, 1633-1643.
Thomas, E., Leroux, J. L., Blotman, F. & Chavis, C. (1995) Inflamm. Res. 44, 121-124.
Gewirtz, A. T., McCormick, B., Neish, A. S., Petasis, N. A., Gronert, K., Serhan, C. N. & Madara, J. L. (1998) J. Clin. Invest. 101, 1860-1869.
Pillinger, M. H. & Abramson, S. B. (1995) Rheum. Dis. Clin. North Am. 21, 691-714.
Hagihara, H., Nomoto, A. Mutoh, S. Yamaguchi, I. & Ono, T. (1991) Atherosclerosis 91, 107-116.
McLaughlan, J. M., Seth, R., Vautier, G., Robins, R. A., Scott, B. B., Hawkey, C. J. & Jenkins, D. (1997) J. Pathol. 181, 87-92.
Anezaki, K., Asakura, H., Honma, T., Ishizuka, K. Funakoshi, K., Tsukada, Y. & Narisawa, R. (1998) Intern. Med. 37, 253-258.
Iverson, L. & Kragballe, K. (1997) in Skin Immune System (SIS), ed. Bos., J. D. (CRC Press, Boca Raton), pp. 227-237.
Ensor, C. M. & Tai, H.-H. (1991) in Prostaglandins, Leukotrienes, Lipoxins, and PAF, ed. Bailey, J. M. (Plenum Press, New York), pp. 39-52.
Serhan, C. N., Fiore, S., Brezinski, D. A. & Lynch, S. (1993) Biochemistry 32, 6313-6319.
Maddox, J. F., Colgan, S. P., Clish, C. B., Petasis, N. A., Fokin, V. V. & Serhan, C. N. (1998) FASEB J. 12, 487-494.
Serhan, C. N., Maddox, J. F., Petasis, N. A., Akritopoulou-Zanze, I., Papayianni, A., Brady H. R., Colgan, S. P. & Madara, J. L. (1995) Biochemistry 34, 14609-14615.
Takano, T. , Clish, C. B., Gronert, K. Petasis, N. & Serhan, C. N. (1998) J. Clin. Invest. 101, 819-826.
Sin, Y. M., Sedgwick, A. D., Chea, E. P. & Weilloughby, D. A. (1986) Ann. Rheum. Dis. 45, 873-877.
Bradley, P. P., Priebat, D. A., Christensen, R. D. & Rothstein, G. (1982) J. Invest. Dermatol. 78, 206-209.
Edwards, J. C. W., Sedgwick, A. D. & Willoughby, D. A. (1981) J. Pathol 134, 147-156.
Tessier, P. A., Naccache, P. H., Clark-Lewis, I., Gladue, R. P., Neote, K. S. & McColl, S. R. (1997) J. Immunol. 159, 3595-3602.
Dahlen, S. E. & Serhan , C. N. (1991) in Lipoxygenases and Their Products, eds. Crooke, S. T. & Wong, A. (Academic Press, San Diego, CA), pp. 235-276.
Katoh, T., Takahashi, K., DeBoer, D. K., Serhan, C. N. & Badr, K. F. (1992) Am. J. Physiol. 263, F436-442.
Marriott, J. B., Westby, M. & Dalgleish, A. G. (1997) Drug Discovery Today 2, 273-282.
Abstract No. 252676t “Neutrophil-Mediated Changes in Vascular Permeability are Inhibited by Topical Application of Aspirin-Triggered 15-epi-Lipoxin A4 and Novel Lipoxin B4 Stable Analogs” Chemical Abstracts, vol. 128, No. 21, p. 41, col. R, (1998).
Grant, S.M. & Goa K.L. (1992) Drugs 43, 899-924.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Prevention of neutrophil recruitment does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Prevention of neutrophil recruitment, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Prevention of neutrophil recruitment will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-4136018

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.